Portola Pharmaceuticals names Scott Garland CEO

Portola Pharmaceuticals announced the appointment of Scott Garland as president and CEO effective October 8. Garland brings to his new role more than two decades of broad executive leadership experience, including a track record driving multiple billion dollar product launches. He will also serve on the company’s board. Garland joins Portola from Relypsa where he was president and previously CCO. During his tenure, Garland was responsible for the integration and growth of the U.S. operations after Relypsa was acquired.
https://thefly.com/landingPageNews.php?id=2793115